- Home
- LKCO vs NCNA Comparison
LKCO vs NCNA Comparison
Compare LKCO & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- NCNA
- Stock Information
- Founded
- LKCO 2009
- NCNA 1997
- Country
- LKCO China
- NCNA United Kingdom
- Employees
- LKCO N/A
- NCNA N/A
- Industry
- LKCO EDP Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- LKCO Technology
- NCNA Health Care
- Exchange
- LKCO Nasdaq
- NCNA Nasdaq
- Market Cap
- LKCO 4.3M
- NCNA 4.9M
- IPO Year
- LKCO N/A
- NCNA 2017
- Fundamental
- Price
- LKCO $1.45
- NCNA $1.23
- Analyst Decision
- LKCO
- NCNA Buy
- Analyst Count
- LKCO 0
- NCNA 2
- Target Price
- LKCO N/A
- NCNA $25.00
- AVG Volume (30 Days)
- LKCO 16.3K
- NCNA 76.3K
- Earning Date
- LKCO 01-07-2025
- NCNA 11-25-2024
- Dividend Yield
- LKCO N/A
- NCNA N/A
- EPS Growth
- LKCO N/A
- NCNA N/A
- EPS
- LKCO N/A
- NCNA N/A
- Revenue
- LKCO $10,236,235.00
- NCNA N/A
- Revenue This Year
- LKCO N/A
- NCNA N/A
- Revenue Next Year
- LKCO N/A
- NCNA N/A
- P/E Ratio
- LKCO N/A
- NCNA N/A
- Revenue Growth
- LKCO N/A
- NCNA N/A
- 52 Week Low
- LKCO $1.43
- NCNA $1.17
- 52 Week High
- LKCO $8.00
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- LKCO 38.38
- NCNA 37.16
- Support Level
- LKCO $1.46
- NCNA $1.23
- Resistance Level
- LKCO $1.75
- NCNA $1.31
- Average True Range (ATR)
- LKCO 0.23
- NCNA 0.07
- MACD
- LKCO 0.00
- NCNA 0.02
- Stochastic Oscillator
- LKCO 2.88
- NCNA 25.00
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.